Comparison of Rosiglitazone Versus Glyburide on Vascular Structure and Function in Type 2 Diabetic Patients
Phase of Trial: Phase IV
Latest Information Update: 12 Jul 2013
At a glance
- Drugs Glibenclamide; Rosiglitazone
- Indications Type 2 diabetes mellitus
- Focus Biomarker; Pharmacodynamics
- 08 Aug 2012 Actual end date (1 Dec 2005) added as reported by ClinicalTrials.gov.
- 03 Dec 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History